Market capitalization of Bristol-Myers Squibb (BMY)

Market cap: NZ$177.79 Billion

As of October 2024 Bristol-Myers Squibb has a market cap of NZ$177.79 Billion. This makes Bristol-Myers Squibb the world's 159th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Bristol-Myers Squibb was reported to be:

NZ$177.79 Billion

by Yahoo Finance

NZ$177.79 Billion

by CompaniesMarketCap

NZ$177.79 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Pfizer PFE	NZ$273.51 B	53.84%	🇺🇸 USA
Merck MRK	NZ$458.74 B	158.03%	🇺🇸 USA
Eli Lilly LLY	NZ$1.362 T	666.51%	🇺🇸 USA
Novartis NVS	NZ$389.21 B	118.92%	🇨🇭 Switzerland
Sanofi SNY	NZ$227.57 B	28.00%	🇫🇷 France
AstraZeneca AZN	NZ$400.11 B	125.05%	🇬🇧 UK
Johnson & Johnson JNJ	NZ$653.62 B	267.64%	🇺🇸 USA
AbbVie ABBV	NZ$549.24 B	208.93%	🇺🇸 USA
Amgen AMGN	NZ$284.71 B	60.14%	🇺🇸 USA
Biogen BIIB	NZ$45.66 B	-74.32%	🇺🇸 USA